Your browser doesn't support javascript.
loading
Study Protocol: Phase I Dose Escalation Study of Oxaliplatin, Cisplatin and Doxorubicin Applied as PIPAC in Patients with Peritoneal Metastases.
Robella, Manuela; Berchialla, Paola; Borsano, Alice; Cinquegrana, Armando; Ilari Civit, Alba; De Simone, Michele; Vaira, Marco.
Afiliação
  • Robella M; Unit of Surgical Oncology, Candiolo Cancer Institute, Fondazione del Piemonte per l'Oncologia-IRCCS, 10060 Candiolo, Italy.
  • Berchialla P; Department of Clinical and Biological Sciences, University of Turin, 10124 Turin, Italy.
  • Borsano A; Unit of Surgical Oncology, Candiolo Cancer Institute, Fondazione del Piemonte per l'Oncologia-IRCCS, 10060 Candiolo, Italy.
  • Cinquegrana A; Unit of Surgical Oncology, Candiolo Cancer Institute, Fondazione del Piemonte per l'Oncologia-IRCCS, 10060 Candiolo, Italy.
  • Ilari Civit A; Unit of Surgical Oncology, Candiolo Cancer Institute, Fondazione del Piemonte per l'Oncologia-IRCCS, 10060 Candiolo, Italy.
  • De Simone M; Unit of Surgical Oncology, Candiolo Cancer Institute, Fondazione del Piemonte per l'Oncologia-IRCCS, 10060 Candiolo, Italy.
  • Vaira M; Unit of Surgical Oncology, Candiolo Cancer Institute, Fondazione del Piemonte per l'Oncologia-IRCCS, 10060 Candiolo, Italy.
Article em En | MEDLINE | ID: mdl-34070561

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Peritoneais / Cisplatino Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Peritoneais / Cisplatino Idioma: En Ano de publicação: 2021 Tipo de documento: Article